4 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp05961 | RGD-mda-7 | MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSGAQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQNVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLANNFVLIVSQLQPSQENEMFSIRGDSAHRRFLLFRRAFKQLDVEAALTKALGEVDILLTWMQKFYKL | Derived from wtmda-7/IL-24 by insertion or a glycine residue between Arg(164) and Asp(165). | Apoptosis inducing | MTT/MTS assay | MCF-7 | Breast cancer | Cell viability(% of control):0.5 at concentration 4 µg/ml |
| dbacp05962 | RGD-mda-7 | MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSGAQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQNVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLANNFVLIVSQLQPSQENEMFSIRGDSAHRRFLLFRRAFKQLDVEAALTKALGEVDILLTWMQKFYKL | Derived from wtmda-7/IL-24 by insertion or a glycine residue between Arg(164) and Asp(165). | Apoptosis inducing | MTT/MTS assay | Ket-3 | Tumor | Cell viability(% of control): 0.5 at concentration 8 µg/ml |
| dbacp05963 | RGD-mda-7 | MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSGAQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQNVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLANNFVLIVSQLQPSQENEMFSIRGDSAHRRFLLFRRAFKQLDVEAALTKALGEVDILLTWMQKFYKL | Derived from wtmda-7/IL-24 by insertion or a glycine residue between Arg(164) and Asp(165). | Apoptosis inducing | MTT/MTS assay | MCF-7 | Breast cancer | Apoptotic rate(%): >70% at concentration of 8 µg/ml |
| dbacp05964 | RGD-mda-7 | MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSGAQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQNVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLANNFVLIVSQLQPSQENEMFSIRDSAHRRFLLFRRAFKQL | Derived from wtmda-7/IL-24 by insertion or a glycine residue between Arg(164) and Asp(165). | Apoptosis inducing | MTT/MTS assay | Ket-3 | Tumor | Apoptotic rate(%): >50% at concentration of 8 µg/ml |